Search

Search Results
Results 7631 - 7640 of 17271 for Active treatment
  • Drug - 7 Oct 2025
    Consumer Medicine Information (CMI) about Celapram intended for persons living in Australia.
  • News - 6 Oct 2025
    International Plasma Awareness Week (IPAW) takes place globally from October 6-10. The week encourages communities around the world to recognize the vital role of plasma in creating lifesaving...
  • Drug - 3 Oct 2025
    Consumer Medicine Information (CMI) about DBL Docetaxel intended for persons living in Australia.
  • News - 3 Oct 2025
    Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets...
  • News - 2 Oct 2025
    In a preclinical study, UC Davis Comprehensive Cancer Center scientists developed a highly targeted gene therapy that could revolutionize treatment for cancers linked to a common herpesvirus, with...
  • Drug - 2 Oct 2025
    Consumer Medicine Information (CMI) about Elrexfio intended for persons living in Australia.
  • Drug - 2 Oct 2025
    Consumer Medicine Information (CMI) about Subutex intended for persons living in Australia.
  • Drug - 2 Oct 2025
    Consumer Medicine Information (CMI) about Suboxone Film intended for persons living in Australia.
  • Drug - 1 Oct 2025
    Consumer Medicine Information (CMI) about Premarin intended for persons living in Australia.
  • Drug - 30 Sep 2025
    Consumer Medicine Information (CMI) about DBL Morphine Sulfate intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.